Correlation Between Iovance Biotherapeutics and Personalis

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Iovance Biotherapeutics and Personalis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Iovance Biotherapeutics and Personalis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Iovance Biotherapeutics and Personalis, you can compare the effects of market volatilities on Iovance Biotherapeutics and Personalis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Iovance Biotherapeutics with a short position of Personalis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Iovance Biotherapeutics and Personalis.

Diversification Opportunities for Iovance Biotherapeutics and Personalis

0.58
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Iovance and Personalis is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Iovance Biotherapeutics and Personalis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Personalis and Iovance Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Iovance Biotherapeutics are associated (or correlated) with Personalis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Personalis has no effect on the direction of Iovance Biotherapeutics i.e., Iovance Biotherapeutics and Personalis go up and down completely randomly.

Pair Corralation between Iovance Biotherapeutics and Personalis

Given the investment horizon of 90 days Iovance Biotherapeutics is expected to generate 0.69 times more return on investment than Personalis. However, Iovance Biotherapeutics is 1.45 times less risky than Personalis. It trades about -0.09 of its potential returns per unit of risk. Personalis is currently generating about -0.12 per unit of risk. If you would invest  1,081  in Iovance Biotherapeutics on August 30, 2024 and sell it today you would lose (141.00) from holding Iovance Biotherapeutics or give up 13.04% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Iovance Biotherapeutics  vs.  Personalis

 Performance 
       Timeline  
Iovance Biotherapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Iovance Biotherapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Personalis 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Personalis has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Iovance Biotherapeutics and Personalis Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Iovance Biotherapeutics and Personalis

The main advantage of trading using opposite Iovance Biotherapeutics and Personalis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Iovance Biotherapeutics position performs unexpectedly, Personalis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Personalis will offset losses from the drop in Personalis' long position.
The idea behind Iovance Biotherapeutics and Personalis pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Bonds Directory
Find actively traded corporate debentures issued by US companies
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.